MIRA
INFORM REPORT
|
Report Date : |
13.04.2007 |
IDENTIFICATION
DETAILS
|
Name : |
CHEMO DRUGS |
|
|
|
|
Registered Office : |
A - 50, G.T. Karnal Road, Industrial Area, New Delhi- 110033, Delhi,
India |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
1982 |
|
|
|
|
|
|
|
Legal Form : |
Subject is a Sole Proprietory Concern. |
|
|
|
|
Line of Business : |
Manufacturer and Exporter of Various Pharmaceutical Formulations, Tablets,
Capsules, Dry Syrup, Syrups and Liquid Orals. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 8000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well-established and reputed concern having satisfactory track.
Proprietor is reported as experienced and respectable businessmen. Trade
relations are reported as fair. Business is active. Payments are usually
corrects and as per commitments. The concern can be considered normal for business dealings at usual trade
terms and conditions. |
LOCATIONS
|
Registered Office : |
A - 50, G.T. Karnal Road, Industrial Area, New Delhi- 110033, Delhi,
India |
|
Tel. No.: |
91-11-27244030 |
|
Fax No.: |
91-11-27218579 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
350 Sq. mts. |
|
Location : |
Owned |
|
|
|
SOLE
PROPRIETOR/PARTNERS/DIRECTORS
|
Name : |
Mr. Gautam Ostawal |
|
Designation : |
Proprietor |
|
Mobile : |
91-9811250309 / 9312277204 |
|
Date of Birth/Age : |
46 Years |
|
Qualification : |
Graduate |
|
Experience : |
25 Years |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Exporter of Various Pharmaceutical Formulations,
Tablets, Capsules, Dry Syrup, Syrups and Liquid Orals. |
|
|
|
|
Terms : |
|
|
Selling : |
Cash, Credit (30 Days) |
|
|
|
|
Purchasing : |
Cash, Credit (30 to 45 Days) |
GENERAL
INFORMATION
|
Suppliers : |
From all Over India |
|
|
|
|
Customers : |
Dealer Network |
|
|
|
|
No. of Employees : |
15 |
|
|
|
|
Bankers : |
Vijaya Bank Ansari Road, Darya Ganj, Delhi - 110002 |
|
|
|
|
Facilities : |
No Over Draft |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
|
|
|
Associates : |
Chemo Remedies |
|
Address : |
A - 50, G.T. Karnal Road, Industrial Area, New Delhi- 110033, Delhi,
India |
|
Established : |
October 2006 |
|
Line of Business : |
Manufacturer of Beet Lacto Drugs |
|
Employees : |
4 |
CAPITAL STRUCTURE
|
Capital Investment : |
|
|
Owned : |
Rs.2.000 Millions |
|
Borrowed : |
--- |
|
Total : |
Rs.2.000 Millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
|
Particulars |
31.03.2007 |
31.03.2006 |
|
|
Sales Turnover |
12.500 |
11.000 |
|
|
|
|
|
|
|
Profit Before Tax |
12 % |
12 % |
|
|
|
|
|
|
|
Profit After Tax |
9 % |
9 % |
|
|
|
|
|
|
Expected Sales (2007-08) : Rs.15.000 millions
LOCAL AGENCY
FURTHER INFORMATION
Website Details
Attached :
Company Profile
Incepted in the year 1979, Chemo Drugs is one of India's distinguished manufacturers
and exporters of Dry Syrups, Liquid Oral, Generic Pharmaceutical Drugs
Formulation, Tablets, Capsules. Chemo's has been making constant efforts to
provide the best in products and services. The realization of its
responsibilities as a pharmaceutical company goes beyond providing the products
it manufactures.
Products
The company is one of the largest manufacturer and exporter of generic drugs
formulation in Delhi. The company manufacture over 100 products in different
dosage forms such as Dry Syrups, Liquid Oral, Generic Pharmaceutical Tablets,
Capsules. At Chemo Drugs, quality precedes all other considerations. The
reliable range of their pharmaceutical capsules, tablets, syrups and liquid
oral includes:
Quality
At, Chemo Drug's The company ensure flawless production and distribution of our
products. The quality control checks done under professional personnel to make
sure that the products meet all international standards. The company has been
awarded with ISO 9001:2000 certification for producing standard quality
products. The Company is also committed to follow current GMP ( Good
Manufacturing Practices).
Infrastructure
The company has an ultra modern manufacturing unit located at Delhi, the
capital of India. Chemo Drug's manufacturing strengths have established it as a
producer of world-class branded / generics and a major supplier. The company
has acquired latest technology and state of the art machinery, backed by a team
of dedicated professionals who have an expertise knowledge in their sphere of
operations. The company has a full-fledged packaging & shipping department
that ensures a safe delivery of the client's order.
Client
As an accomplished pharmaceutical company, It’s products are known for superior
quality and reliability by their valuable clients all over the world.
Products :
Sr.No. Name of the Item Sr .No.
Name of the Item
TABLETS 42 Tabs. Mefenamic Acid 250 mg. +
Dicyclomine 10mg
1 Sildenafil Citrate 25/50/100 mg. Tablet 43 Tabs.
Dilcofenac Sod. 50mg. + Chlorzoxazone
500mg +
Paracetamo l500mg
2 Cefdinir 300 mg. Capsule/ Dry Syrup 44 Tabs.Para.
500 mg.+ Caffeine 30 mg. Chlorpheniramine
Maleate
2 mg. Phenylpropanolamine 12.5mg
3 Pentaprazole 40 mg. Tablet 45 Anti Cold Tabs. Paracetamol 500mg + Caffeine 30mg +
CP
Maleate 2mg.
4 Gatifloxacin 200/400 mg. Tablet 46 Tabs.
Ibuprofen 400mg. + Paracetamol 325mg. +
Caffeine
30mg.
5 Levofloxacin
250/500/750 mg. Tablet 47 Tabs. Nimesulide 100mg / 100mg mouth
dissolve.
6 Pioglitazone
15/30 mg. Tablet 48 Tabs.Nimesulide 100mg. + Para 500mg.
7 Glucosamine
500 mg. Tablet 49 Tabs. Albendazole 400mg.
8 Ondansetron 4/8 mg. Tablet 50 Tabs. Sarrtiopeptidase 10 mg / Diclofenae Pottasium
50mg.
9 Sertraline
50/100 mg. Tablet 51 Tabs. Piroxicam 20 mg. (DT)
10 Progesterone
100/200 mg. Tablet 52 Tabs. Atenolol 50mg.+ Amlodipine 5mg.
11 Lactulose
10 gm. Solution 53 Tabs. Metformin500mg.+ Glyclazide 80
mg.
12 Multivitamin
Tablet/ Syrup 54 Tabs. Calcium Carbonate with Vitamin D
3
13 Tricholine
Citrate 3.575 gm.
+
Sorbitol 3.575 gm + Cyproheptadine
2
mg Syrup 55 Tabs. Calcilum Citrate with Mag..,Zinc
& Vit. D3
14 Amoxycillen
+ Pot. Calavulauate
Tablet/ Dry Syrup 56 Tabs. Rifampicin 450 mg.
15 Lactic
Acid Bacillus 60 million
spores Tablet 57 Tabs. Rifampicin 150mg + Isoniazide
100mg + Pyrazinamide 500mg
16 Cephalexin
Tablet/ Capsule/ Dry Syrup 58 Tabs. Sulphadoxine 500mg. +
Pyramethamine 25mg.
17 Ofloxacin
+ Tinidazole Tablet CAPSULES
18 Ofloxadcin
+ Ornidazole Tablet 59 Caps. Amoxycillin 250/500 mg.
19 Ofloxacin
+ Metronidazole Syrup 60 Caps. Lincomycin 500 mg.
20 All
Purinol Tablet 61 Caps. Omeprazole Capsules 20 mg./40mg
21 Silimarin
Tablet 62 Caps. Lansoprazole 15mg./30 mg.
22 Cifadroxil
Tablet / Capsule 63 Caps. Fluoxetine HCl. 20 mg.
23 Magaldrate
+ Simethicme Syrup 64 Caps. Ginseng With Vitamin B-Complex,
Zinc & Vitamin E
24 Tabs. Azithromycin Tablets 250 mg
/ 500mg. 65 Caps. Anti-oxidant (Vit.A,E,C, Selinium
Zinc,Mag. & Copper)
25 Tabs.
Fluconazole Tablets 150 mg. 66 Caps. Iron with Vit. C & B12
26 Tabs.
Ketoconazole 200mg. SYRUPS/LIQUID ORALS
27 Tabs.
Cetirizine Dihydrochloride 10mg 67 Syp .Chloramphenicol 125mg.
28 Tabs.
Ofloxacin 100 mg./200
mg./400mg. 68 Syp. Norfloxacin 100mg +
Metronidazole150mg.
29 Tabs. Roxithromycin 50/150mg. 69 Susp..
Aluminium 200 mg + Magnesium 200 mg. + Simethicone 25 mg.
30 Tabs.
Norffloxacin 400mg. 70 Syrup. Iron with Vitamin B-Complex.
31 Tabs.
Ciprofloxacin 250/500/750 mg. 71 Susp. Nimesulide 50mg
32 Tabs.
Amoxycillin 125/250 mg. (DT). 72 Syp. Calcium with Vitamin D 3
33 Tabs. Cefuroxime Axetil 125/250/500mg. 73 Cough
Syp. Chlorpheniramine Mal. 2mg. + Dextromethorphen 10mg. +
Phenylpropanolamine 12.5mg
34 Tabs.
Cefixime 200 /100 mg. Dry Syrup 74 Drops/Syp. Iron Polymaltose 50mg/ml./5ml.
35 Tabs.
Tinidazole 500 mg. 75 Syrup.L- Lysine with Vit. B.Complex.
36 Tabs.
Famotidine 20mg./40 mg. 76 Syrup Protein with Vitmin B-Complex.
37 Tabs.
Cimetidine 200mg./ 400 mg. 77 Atorvastatin Tablet
38 Tabs.
Domperidone 10 mg. 78 Baclofen Tablet
39 Tabs.
Ciprofloxacin 500mg. +
Tinidazole
600mg. 79 Sucarlfate Tablet/Syrup
40 Tabs.
Norfloxacin 400 mg +
Tinidazole
600 mg. 80 MefeuamicAcid + Dicyclomine Tablets
41 Tabs. Norfloxacin
100/200/400 mg +
42 Metronidazole
100/300/600 mg. 81 Cefpodoxim Proxetil Tablet/Dry Syrup
82 Piracetam Tablet/Syrup
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.42.74 |
|
UK Pound |
1 |
Rs.84.90 |
|
Euro |
1 |
Rs.57.79 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
48 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|